Stock Analiz

Amphastar Pharmaceuticals, Inc. (AMPH) stock forecast and price target

Price $29.37 · data as of November 13, 2026

12-month price target

Average target$24.50
Upside / downside−16.6%
Analysts6
ConsensusHold
Low $20.00Average $24.50High $30.00

Gold marker: average target · white marker: today’s price ($29.37)

Analyst ratings

Strong buy 0Buy 0Hold 6Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$3.20−1.6%$758M
Next fiscal year
ends December 31, 2027
$2.69+4.8%$792M
Next quarter
ends December 31, 2026
$0.73+7.9%$196M
Quarter after
ends March 31, 2027
$0.74+76.9%$186M

Consensus of the analysts covering Amphastar Pharmaceuticals, updated daily. In the last 30 days 4 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 16.6% downside over 12 months. Our discounted cash flow model with moderate assumptions puts Amphastar Pharmaceuticals’s intrinsic value about 38% above today’s market value, and it scores 3.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Amphastar Pharmaceuticals stock price target?

The average 12-month target from 6 analysts is $24.50, 16.6% below the current price of $29.37 Targets range from $20.00 to $30.00.

Is Amphastar Pharmaceuticals a buy according to analysts?

The consensus rating is “Hold” (6 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Amphastar Pharmaceuticals expected to earn?

Analysts expect EPS of $3.20 for the fiscal year ending December 31, 2026 and $2.69 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.